Search clinical trials for: Hyperfine

Total 26 results

Children's Mercy Hospital Kansas City

Recruiting

Low Field Magnetic Resonance Imaging Assessment With Outpatients

Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound

United States
Children's Mercy Hospital Kansas City

Recruiting

Low Field and High Field Magnetic Resonance Imaging Assessments on Pediatric Patients

Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound

United States
Children's Mercy Hospital Kansas City

Recruiting

Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation

Extracorporeal Membrane Oxygenation Complication | Acute Brain Injury | Feasibility and Safety of a Low-field MRI

United States
University of Pennsylvania

Recruiting

Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging

Neurological Disorder | Hydrocephalus

United States
University of Pennsylvania

Completed

Ferumoxytol Enhanced Hyperfine Low Field Strength MRI

Anemia, Hemolytic

United States
Biomedisyn Corporation
Yale University

Completed

Huperzine for Cognitive and Functional Impairment in Schizophrenia

Schizophrenia

United States
University of Miami
HyperVibe Pty Ltd

Withdrawn

Whole Body Vibration Training on Body Composition

Body Composition, Beneficial | Physical Fitness

United States
SK Life Science, Inc.

Completed

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Partial Epilepsy

Australia, United States, Korea, Republic of, Germany, Hungary, Serbia, Bulgaria, Czechia, France, Israel, Poland, Romania, Spain, Thailand, Ukraine
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Completed

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence

Substance Abuse | Cocaine Dependence | Cocaine Abuse | Cocaine Addiction

United States
Jiangsu Famous Medical Technology Co., Ltd.

Unknown

Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage

Neurosensory Disorder

China
Second Affiliated Hospital of Wenzhou Medical University
The First People's Hospital of Wenling

Recruiting

A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery

Injection | Delirium in Old Age | Post Operative Delirium | Non-cardiac Surgery

China
VA Nebraska Western Iowa Health Care System
American Legion of Iowa Foundation

Unknown

Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia

Schizophrenia | Dementia

United States
Wanbangde Pharmaceutical Group Co., LTD
Second Affiliated Hospital, School of Medicine, Zhejiang University

Not yet recruiting

The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study

Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage

China
Shandong Luye Pharmaceutical Co., Ltd.

Unknown

Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

Alzheimer's Disease

China
Supernus Pharmaceuticals, Inc.

Recruiting

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Epilepsy | Seizures, Epileptic

Australia
Supernus Pharmaceuticals, Inc.

Active, not recruiting

BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures (FIAS)

Focal Impaired Awareness Seizures

Australia
Zhijun Bao

Enrolling by invitation

Effects of Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)

Cognitive Impairment | Tinnitus | Presbycusis

China
Hadassah Medical Organization
Hebrew University of Jerusalem

Unknown

Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A

Healthy | Bioavailability

Israel
National Institute on Aging (NIA)
Alzheimer's Disease Cooperative Study (ADCS); Neuro-Hitech

Completed

Huperzine A in Alzheimer's Disease

Alzheimer Disease

United States
St. Louis University

Completed

Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise

Cognitive Enhancement During Exercise

United States
Spaulding Rehabilitation Hospital

Terminated

Effects of Huperzine A in Treatment of Moderate to Severe TBI

Traumatic Brain Injury

United States
Supernus Pharmaceuticals, Inc.
Melbourne Health

Completed

Bioavailability, Safety, and Tolerability of BIS-001 ER

Epilepsy, Complex Partial

Australia
Shanghai Mental Health Center

Not yet recruiting

Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging

Mild Cognitive Impairment | Treatment | Diagnosis | Biomarker

China
Supernus Pharmaceuticals, Inc.

Completed

Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects

Healthy Volunteer

Australia
Amen Clinics, Inc.

Completed

Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players

Traumatic Brain Injury

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance

Biomarkers, Pharmacological

United States

Search clinical trials for: Hyperfine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations